Serplulimab
Serplulimab Basic information
- Product Name:
- Serplulimab
- Synonyms:
-
- Serplulimab
- Research Grade Serplulimab (DHH02213)
- Serplulimab (anti-PDCD1)
- HLX 10
- Research Grade Serplulimab
- CAS:
- 2231029-82-4
- MW:
- 0
- Mol File:
- Mol File
More
Less
Serplulimab Chemical Properties
- storage temp.
- Store at -20°C
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Serplulimab Usage And Synthesis
Uses
Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody. Serplulimab can be used in research of small cell lung cancer[1].
References
[1] Lee A. Serplulimab: First Approval. Drugs. 2022 Jul;82(10):1137-1141. DOI:10.1007/s40265-022-01740-0
SerplulimabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
More
Less
Serplulimab(2231029-82-4)Related Product Information
- Bapotulimab
- Immunoglobulin G1,anti-(human CD19 (antigen)) (mouse monoclonal B43 g1-chain), disulfide with mouse monoclonal B43 k-chain, dimer, disulfide withprotein PAP (pokeweed antiviral) (9CI)
- Retifanlimab
- Indatuximab Ravtansine
- Relfovetmab
- Zelminemab
- Bafisontamab
- Quilizumab
- Elgemtumab
- Lacnotuzumab